Biotalys NV
24.2.2026 18:00:00 CET | Globenewswire | Press release
Biotalys Notice of Publication 2025 Annual Report and Financial Results
Biotalys Notice of Publication 2025 Annual Report and Financial Results
Webcast and Conference Call to take place on Friday, 27 March 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ET
Ghent, BELGIUM, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Press release
Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its annual report and consolidated financial results for the full year of 2025 on Friday, 27 March 2026 at 07:00 CET.
Webcast and Conference Call
In addition to the publication of its results, management will host a webcast and conference call followed by a Q&A session, conducted in English. The webcast will be held on Friday, 27 March 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ET and can be accessed via the following link:
https://edge.media-server.com/mmc/p/f4cri5hy.
To ask live questions to the management, please register for the conference call via the following link: https://register-conf.media-server.com/register/BI5166f65ce5be4a02bf5d80a0bc047aaa.
A recording of the webcast will be available after the event on the Biotalys investor website: https://www.biotalys.com/investors/financial-information.
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact:
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com
Attachments
- Biotalys Notice of FY 2025 Results and Business Highlights_ENG
- Biotalys aankondiging publicatiedatum financiële resultaten en bedrijfshoogtepunten van 2025
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brookfield Corporation21.9.2026 23:15:00 CEST | Press release
Brookfield Corporation Announces Pricing of $600 Million Notes Due 2031
Azerion Group NV21.9.2026 18:02:48 CEST | Press release
Azerion Group N.V. Publishes bond prospectus and applies for admission to trading of its bonds on Nasdaq Stockholm
F. Hoffmann-La Roche Ltd21.9.2026 17:45:00 CEST | Press release
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
Cority Software Inc.21.9.2026 17:24:28 CEST | Press release
Cority Named a Leader in 2026 Verdantix Green Quadrant for EHS Software for Seventh Consecutive Year
Unlimit Group A/S21.9.2026 17:07:14 CEST | Pressemeddelelse
Unlimit Group A/S: Ledende medarbejders og disses nærtstående transaktioner med Unlimit-aktier
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom